KLCM Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
8,667
+631
+8% +$147K 0.18% 79
2025
Q4
$1.66M Buy
8,036
+1,047
+15% +$207K 0.14% 82
2025
Q3
$1.3M Sell
6,989
-195
-3% -$33.4K 0.13% 80
2025
Q2
$1.1M Buy
7,184
+109
+2% +$16.8K 0.12% 79
2025
Q1
$1.17M Sell
7,075
-111
-2% -$17.4K 0.14% 76
2024
Q4
$1.04M Buy
7,186
+140
+2% +$21.7K 0.12% 79
2024
Q3
$1.14M Sell
7,046
-210
-3% -$33.5K 0.14% 75
2024
Q2
$1.06M Sell
7,256
-13
-0.2% -$1.93K 0.13% 66
2024
Q1
$1.15M Buy
7,269
+103
+1% +$16.4K 0.15% 64
2023
Q4
$1.12M Sell
7,166
-288
-4% -$44.2K 0.17% 60
2023
Q3
$1.16M Sell
7,454
-81
-1% -$13.4K 0.22% 56
2023
Q2
$1.25M Buy
7,535
+1,055
+16% +$170K 0.24% 54
2023
Q1
$1M Buy
6,480
+646
+11% +$104K 0.2% 60
2022
Q4
$1.03M Buy
5,834
+129
+2% +$22.3K 0.21% 58
2022
Q3
$932K Buy
5,705
+1,122
+24% +$190K 0.22% 57
2022
Q2
$814K Sell
4,583
-2
-0% -$356 0.18% 59
2022
Q1
$813K Sell
4,585
-1,266
-22% -$215K 0.17% 57
2021
Q4
$1M Sell
5,851
-370
-6% -$60.6K 0.22% 51
2021
Q3
$1M Buy
6,221
+116
+2% +$19.8K 0.22% 50
2021
Q2
$1.01M Sell
6,105
-196
-3% -$32.4K 0.22% 47
2021
Q1
$1.04M Buy
6,301
+63
+1% +$10.2K 0.24% 50
2020
Q4
$982K Sell
6,238
-209
-3% -$30.8K 0.24% 49
2020
Q3
$960K Sell
6,447
-7,143
-53% -$1.06M 0.28% 47
2020
Q2
$1.91M Sell
13,590
-139
-1% -$20.3K 0.54% 33
2020
Q1
$1.8M Buy
13,729
+203
+2% +$28.8K 0.57% 31
2019
Q4
$1.97M Sell
13,526
-595
-4% -$80.7K 0.44% 35
2019
Q3
$1.83M Buy
14,121
+381
+3% +$50.2K 0.47% 32
2019
Q2
$1.91M Buy
13,740
+19
+0.1% +$2.63K 0.47% 32
2019
Q1
$1.92M Buy
13,721
+425
+3% +$56.9K 0.47% 32
2018
Q4
$1.72M Buy
13,296
+662
+5% +$92.3K 0.5% 30
2018
Q3
$1.75M Sell
12,634
-175
-1% -$23.3K 0.43% 33
2018
Q2
$1.55M Buy
12,809
+683
+6% +$85.2K 0.41% 33
2018
Q1
$1.55M Buy
12,126
+772
+7% +$104K 0.42% 31
2017
Q4
$1.59M Buy
11,354
+118
+1% +$16.4K 0.39% 33
2017
Q3
$1.46M Buy
11,236
+1,902
+20% +$252K 0.38% 31
2017
Q2
$1.24M Hold
9,334
0.34% 32
2017
Q1
$1.16M Sell
9,334
-800
-8% -$95.6K 0.33% 34
2016
Q4
$1.17M Buy
10,134
+1,700
+20% +$196K 0.34% 33
2016
Q3
$996K Sell
8,434
-1,869
-18% -$227K 0.32% 35
2016
Q2
$1.25M Buy
10,303
+1,319
+15% +$150K 0.43% 30
2016
Q1
$972K Buy
8,984
+1,200
+15% +$124K 0.34% 31
2015
Q4
$800K Sell
7,784
-100
-1% -$10.1K 0.29% 30
2015
Q3
$736K Sell
7,884
-3,997
-34% -$387K 0.26% 31
2015
Q2
$1.16M Buy
11,881
+2,827
+31% +$283K 0.29% 28
2015
Q1
$911K Buy
9,054
+135
+2% +$13.7K 0.25% 29
2014
Q4
$933K Buy
8,919
+135
+2% +$14.2K 0.24% 30
2014
Q3
$936K Hold
8,784
0.25% 29
2014
Q2
$919K Sell
8,784
-600
-6% -$60.6K 0.21% 34
2014
Q1
$922K Buy
9,384
+487
+5% +$45.1K 0.25% 32
2013
Q4
$815K Sell
8,897
-138
-2% -$12.7K 0.22% 33
2013
Q3
$783K Buy
9,035
+138
+2% +$12.4K 0.22% 33
2013
Q2
$764K Buy
+8,897
New +$755K 0.24% 32

Other funds holding JNJ

KLCM Advisors's JNJ Position: Q1 2026 in Review

KLCM Advisors increased its Johnson & Johnson (JNJ) stake by 7.9% in Q1 2026, buying an estimated $147K and bringing the position to 8,667 shares worth $2.12M. The position accounts for 0.18% of the portfolio, ranked #79.

KLCM Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • KLCM Advisors held 8,667 shares of Johnson & Johnson worth $2.12M as of Q1 2026.
  • KLCM Advisors bought 631 Johnson & Johnson shares in Q1 2026, an estimated $147K.
  • Johnson & Johnson made up 0.18% of KLCM Advisors's portfolio in Q1 2026, its #79 holding.
  • KLCM Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on KLCM Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.